Ángel Sevillano - Concepedia

Author

Ángel Sevillano

Also Known As

A Sevillano, A. M. Sevillano, A. Sevillano, A.M. Sevillano, Angel M Sevillano, Angel M Sevillano Prieto, Angel M. Sevillano, Angel Sevillano, Angel Sevillano-Prieto, Á. Sevillano

114

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Universidad Complutense de Madrid Research Institute Hospital 12 de Octubre Hospital Universitario 12 De Octubre Hospital Universitario Fundación Jiménez Díaz Hospital Universitario Fundación Alcorcón

ÁS

About

Ángel Sevillano is an author at Universidad Complutense de Madrid specializing in medicine, nephrology, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	649
2	Engineering	1	1	62
3	Health Sciences	1	1	64
4	Anesthesia	1	1	169
5	Biomedical Engineering	1	1	62

Ángel Sevillano

Publications

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink, The Lancet	2023	224
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy Gema Fernández‐Juárez, Jorge Rojas-Rivera, Anne-Els van de Logt, Kidney International	2020	220
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers, The Lancet GlomerulonephritisActive-controlled Clinical TrialRenal FunctionKidney FailureChronic Kidney Disease	2023	203
Anaesthetic depth and complications after major surgery: an international, randomised controlled trial Timothy G. Short, Douglas Campbell, Christopher Frampton, The Lancet Major SurgeryMedicinePatient SafetyAnesthesia PracticeOutcomes Research	2019	169
Eculizumab in secondary atypical haemolytic uraemic syndrome Teresa Cavero, Cristina Rabasco, Antía López, Nephrology Dialysis Transplantation	2016	160
Remission of Hematuria Improves Renal Survival in IgA Nephropathy Ángel Sevillano, Eduardo Gutiérrez, Claudia Yuste, Journal of the American Society of Nephrology	2017	153
SARS-CoV-2 Infection in Hospitalized Patients With Kidney Disease Hernando Trujillo, Fernando Caravaca‐Fontán, Ángel Sevillano, Kidney International Reports	2020	77
Podocytes are new cellular targets of haemoglobin‐mediated renal damage Alfonso Rubio‐Navarro, María Dolores Sánchez-Niño, Melania Guerrero‐Hue, The Journal of Pathology Renal PathologyRenal InflammationCell DeathGreat BritainRedox Biology	2017	64
CD163-Macrophages Are Involved in Rhabdomyolysis-Induced Kidney Injury and May Be Detected by MRI with Targeted Gold-Coated Iron Oxide Nanoparticles Alfonso Rubio‐Navarro, Mónica Carril, Daniel Padró, Theranostics NanoparticlesEngineeringImmunologyRenal InflammationPathology	2016	62
Tranexamic acid in coronary artery surgery: One-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trial Paul S. Myles, Julian A. Smith, Jessica Kasza, Journal of Thoracic and Cardiovascular Surgery ThrombosisCardiovascular DiseaseCoronary Artery DiseaseOne-year ResultsCoronary Artery Surgery	2018	59

Page 1